HYPE: Cordyceps boosts oxygen use and gives athletes substantially better endurance.
But what does the evidence actually show?
There are encouraging human findings, but they are inconsistent and highly dependent on the preparation and study. Some trials use mushroom blends, and results in recreationally active or older adults cannot be assumed to apply to trained athletes. A dependable VO₂ max or race-performance boost is not established.
Claim assessed: Cordyceps supplementation produces a reliable, meaningful improvement in human endurance performance or maximal aerobic capacity, including in trained athletes.
Why the performance story is plausible
Cordyceps-related fungi contain compounds investigated for effects on energy metabolism, inflammation and fatigue-related pathways. Those mechanisms make exercise research reasonable. They do not establish that an ordinary supplement measurably improves oxygen delivery or racing performance. [1]
'Cordyceps' also covers different materials: species, cultured mycelium, extracts and blends vary. Cordyceps militaris and preparations sold as Cordyceps sinensis or Cs-4 are not interchangeable interventions. That creates a major obstacle to treating every positive result as support for any product.
The recent reviews show a mixed picture
A 2025 systematic review of fungal supplements included 14 trials overall, with only a subset contributing to particular pooled outcomes. It reported positive Cordyceps sinensis signals for endurance, ventilatory threshold and peak oxygen uptake. The total number of participants across all fungi should not be presented as the number supporting a Cordyceps claim. [2]
A 2026 review focused on Cordyceps militaris identified five intervention studies. It described inconsistent findings, small samples, variable preparations, limited trial registration and frequent use of multi-ingredient products. Those limitations make certainty about the size and practical importance of a benefit low. [1]
The reviews ask overlapping but different questions. One positive meta-analytic result does not erase the need to examine which species, participants and outcomes generated it.
A commonly cited positive study used a blend
A small placebo-controlled study in young adults investigated a mushroom blend containing Cordyceps militaris. Twenty-eight participants completed its first phase, while a smaller subset continued longer. Selected exercise improvements were reported after the longer exposure. [3]
That is a reason for further study, but not clean evidence that Cordyceps alone caused the effect. A small extension is particularly vulnerable to imprecision and selective continuation. The findings also cannot establish what a different extract would do in a well-trained athlete.
A trained-cyclist trial was negative
In a double-blind trial, 22 endurance-trained male cyclists received a Cs-4 preparation or placebo for five weeks. There was no significant improvement in the measured aerobic or endurance-performance outcomes. [4]
This does not prove every Cordyceps formulation is ineffective. It does show why a claim about trained athletes needs direct evidence in that population. Fitness level, training load, product composition and study duration may influence results, but proposed explanations for a negative trial should themselves be tested.
VO₂ max is not the same as lasting longer in a test
Maximal or peak oxygen uptake, ventilatory threshold, time to exhaustion and a fixed-distance time trial measure different aspects of performance. A participant might last longer in a laboratory task without a confirmed rise in VO₂ max or a meaningful reduction in race time.
Similarly, a percentage increase from baseline is less informative than the difference compared with placebo, particularly when both groups are exercising or becoming familiar with the test. A statistically detectable laboratory change also needs to be large and reproducible enough to matter outside that setting.
The catch and safety
For a reliable recommendation, we need well-characterised single-ingredient preparations, adequate samples, preregistered outcomes and replication in comparable athletes. At present there is no defensible universal figure for how much a consumer's VO₂ max or race time will improve.
Short studies cannot establish uncommon or long-term adverse effects. Product identity, contamination and other ingredients remain concerns, especially for competitive athletes subject to testing. Check medicines and medical conditions with a qualified professional; do not assume a mushroom-derived product is interaction-free. Avoid using a supplement to mask unexplained breathlessness, marked fatigue or a sudden loss of exercise capacity.
What this means for you
Training, recovery and adequate fuelling have clearer practical roles than expecting a Cordyceps supplement to transform endurance. If considering one, look for a human trial of the exact preparation in people who resemble you, measuring the performance outcome you care about.
A mushroom blend study or a positive test in less-trained adults is not enough to promise an athlete a faster race or higher VO₂ max.
A possible performance signal; a consistent athletic upgrade remains unproven.
Research & Sources
1. Current Evidence of Cordyceps militaris in Humans (2026)
Review of five intervention studies and important methodological limitations.
Read the source2. Fungal supplementation meta-analysis (2025)
Broader fungal review; Cordyceps-specific pooled signals must be distinguished from totals across fungi.
Read the source3. Hirsch et al.: Cordyceps-containing blend
Small repeated-measures exercise study; attribution limited by multi-ingredient formulation.
Read the source4. Parcell et al. (2004)
Placebo-controlled Cs-4 study in trained cyclists; no performance advantage demonstrated.
Read the sourceEvidence reviewed: October 2026
Evidence vs Hype explains scientific research for educational purposes and does not provide individual medical diagnosis or treatment.